 A live audio webcast of the presentation will be available on the Events and Presentations page of the Investors section of the Companys website The Companys lead product, MacrilenTM macimorelin, is the first and only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency AGHD. 